74. Prolactin secreting pituitary adenoma Clinical trials / Disease details


Clinical trials : 18 Drugs : 33 - (DrugBank : 10) / Drug target genes : 16 - Drug target pathways : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03038308
(ClinicalTrials.gov)
September 16, 201630/1/2017Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist RopiniroleTreatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and TolerabilityHyperprolactinemia;ProlactinomaDrug: RopiniroleColumbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting18 Years70 YearsAll23Phase 1/Phase 2United States